A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
NOVOLIN N insulin is a prescription drug that is used to treat hyperglycemia. NOVOLIN N contains a type of insulin called isophane insulin, which is a modified version of regular human insulin.
Isophane insulin (NPH insulin) is an intermediate-acting insulin that begins working in about one hour and can continue working for about 12-16 hours.
NOVOLIN N insulin provides “basal” insulin that helps achieve glycemic control around the clock.
Inject NOVOLIN N insulin under the skin one to two times daily. The prescriber will determine the most appropriate dose based on patient characteristics.
Rotate injection sites to avoid lipodystrophy and localized cutaneous amyloidosis.
NOVOLIN N insulin can be mixed with regular human insulin.
Once the vial is opened, it can be stored at room temperature for 28 days and then discarded.
The active ingredient in NOVOLIN N is isophane insulin human suspension.
Several drugs can affect blood sugar. If you are taking any of the following drugs, they can increase or decrease blood sugar. Changes in blood sugar may require adjustments to the insulin dose:
Never share NOVOLIN N insulin pens with other patients, even if the pen needles have been changed.
NOVOLIN N can cause hypoglycemia (low blood sugar), which can be life-threatening. The signs of hypoglycemia often include:
Monitor blood sugar frequently while taking NOVOLIN N and other insulin products.
The most common side effects of NOVOLIN N include: